| Naslov: | Simvastatin is effective in killing the radioresistant breast carcinoma cells |
|---|
| Avtorji: | ID Aschenbrenner, Bertram (Avtor)
ID Negro, Giulia (Avtor)
ID Savic, Dragana (Avtor)
ID Sorokin, Maxim (Avtor)
ID Buzdin, Anton A. (Avtor)
ID Ganswindt, Ute Maria (Avtor)
ID Čemažar, Maja (Avtor)
ID Serša, Gregor (Avtor)
ID Skvortsov, Sergej (Avtor)
ID Skvortsova, Ira (Avtor) |
|---|
| Datoteke: |  URL - Izvorni URL, za dostop obiščite https://sciendo.com/article/10.2478/raon-2021-0020
 PDF - Predstavitvena datoteka, prenos (1,76 MB)
MD5: 6EA4208607993EC488B9FD489B0C765C
|
|---|
| Jezik: | Angleški jezik |
|---|
| Tipologija: | 1.01 - Izvirni znanstveni članek |
|---|
| Organizacija: |  OI - Onkološki inštitut Ljubljana
|
|---|
| Povzetek: | Background. Statins, small molecular 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, are widely used to lower cholesterol levels in lipid-metabolism disorders. Recent preclinical and clinical studies have shown that statins exert beneficial effects in the management of breast cancer by increasing recurrence free survival. Unfortunately, the underlying mechanisms remain elusive. Materials and methods. Simvastatin, one of the most widely prescribed lipophilic statins was utilized to investigate potential radiosensitizing effects and an impact on cell survival and migration in radioresistant breast cancer cell lines. Results. Compared to parental cell counterparts, radioresistant MDA-MB-231-RR, T47D-RR andAu565-RR cells were characterized by upregulation of 3-hydroxy-3-methylglutharyl-coenzyme A reductase (HMGCR) expression accom-panied by epithelial-to-mesenchymal transition (EMT) activation. Radioresistant breast cancer cells can be killed by simvastatin via mobilizing of a variety of pathways involved in apoptosis and autophagy. In the presence of simvasta-tin migratory abilities and vimentin expression is diminished while E-cadherin expression is increased. Conclusions. The present study suggests that simvastatin may effectively eradicate radioresistant breast carcinoma cells and diminish their mesenchymal phenotypes. |
|---|
| Ključne besede: | radiotherapy, breast cancer, radioresistant cells |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Datum objave: | 01.09.2021 |
|---|
| Založnik: | Association of Radiology and Oncology |
|---|
| Leto izida: | 2021 |
|---|
| Št. strani: | str. 305-316, VI |
|---|
| Številčenje: | Vol. 55, no. 3 |
|---|
| Izvor: | Ljubljana |
|---|
| PID: | 20.500.12556/DiRROS-19620  |
|---|
| UDK: | 602 |
|---|
| ISSN pri članku: | 1318-2099 |
|---|
| DOI: | 10.2478/raon-2021-0020 |
|---|
| COBISS.SI-ID: | 78947843 |
|---|
| Avtorske pravice: | by Authors |
|---|
| Datum objave v DiRROS: | 22.07.2024 |
|---|
| Število ogledov: | 310 |
|---|
| Število prenosov: | 233 |
|---|
| Metapodatki: |    |
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
